143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Protein shapes matter in Alzheimer's research

Protein shapes matter in Alzheimer's research

by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences

Protein shapes matter in Alzheimer's research

by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences
Aging reduces the ability of regulatory T cells to enhance myelin regeneration, study finds

Aging reduces the ability of regulatory T cells to enhance myelin regeneration, study finds

byMiguel Hernandez University of ElcheA Diagram explaining the experimental design of in vivo Treg depletion, Treg adoptive transfer and spinal cord demyelination. Representative images of immun

Aging reduces the ability of regulatory T cells to enhance myelin regeneration, study finds

byMiguel Hernandez University of ElcheA Diagram explaining the experimental design of in vivo Treg depletion, Treg adoptive transfer and spinal cord demyelination. Representative images of immun
Dopamine treatment found to alleviate symptoms in Alzheimer's disease

Dopamine treatment found to alleviate symptoms in Alzheimer's disease

byRIKENImmunostaining of Aβ (Green) detected by N1D antibody from frontal cortices of 12-month-old AppNL-F; DAT-Cre mice infected with or without the viral vectors AAV8-hSyn-DIO-mCherry and AAV8

Dopamine treatment found to alleviate symptoms in Alzheimer's disease

byRIKENImmunostaining of Aβ (Green) detected by N1D antibody from frontal cortices of 12-month-old AppNL-F; DAT-Cre mice infected with or without the viral vectors AAV8-hSyn-DIO-mCherry and AAV8
How are 'super agers' protected from Alzheimer's and mental decline?

How are 'super agers' protected from Alzheimer's and mental decline?

by Alan Mozes Healthday Reporter(HealthDay)—Some older folks are still sharp as tacks and dementia-free well into their 80s and beyond. Now German researchers have uncovered a possible reason why: The

How are 'super agers' protected from Alzheimer's and mental decline?

by Alan Mozes Healthday Reporter(HealthDay)—Some older folks are still sharp as tacks and dementia-free well into their 80s and beyond. Now German researchers have uncovered a possible reason why: The
Could sudden infant death syndrome be caused by unrecognized brain infections?

Could sudden infant death syndrome be caused by unrecognized brain infections?

by Nancy Fliesler,Children's Hospital BostonCredit: Pixabay/CC0 Public DomainSome infants who pass away from sudden infant death syndrome (SIDS) are known to have had acute minor infections.

Could sudden infant death syndrome be caused by unrecognized brain infections?

by Nancy Fliesler,Children's Hospital BostonCredit: Pixabay/CC0 Public DomainSome infants who pass away from sudden infant death syndrome (SIDS) are known to have had acute minor infections.
Protein modification of a gene expression regulator can confer neuroprotection against inflammation

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera
Research shortfall on common form of dementia highlighted

Research shortfall on common form of dementia highlighted

by University of ExeterJoan Grose had Lewy body dementia. Credit: University of ExeterNew research published inThe Lancethas highlighted the scarcity of evidence on the prognosis of d

Research shortfall on common form of dementia highlighted

by University of ExeterJoan Grose had Lewy body dementia. Credit: University of ExeterNew research published inThe Lancethas highlighted the scarcity of evidence on the prognosis of d
'Curved' walking and a depth camera: New tool detects early cognitive decline

'Curved' walking and a depth camera: New tool detects early cognitive decline

by Florida Atlantic UniversityMahmoud Seifallahi (seated) and Behnaz Ghoraani, Ph.D., reviewing walking performance using a depth camera, which can detect and track 25 joints of body movement. Cr

'Curved' walking and a depth camera: New tool detects early cognitive decline

by Florida Atlantic UniversityMahmoud Seifallahi (seated) and Behnaz Ghoraani, Ph.D., reviewing walking performance using a depth camera, which can detect and track 25 joints of body movement. Cr
Hit the sleep 'sweet spot' to keep brain sharp

Hit the sleep 'sweet spot' to keep brain sharp

by Washington University School of MedicineCredit: CC0 Public DomainLike so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short an

Hit the sleep 'sweet spot' to keep brain sharp

by Washington University School of MedicineCredit: CC0 Public DomainLike so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short an
New Alzheimer trial to use epilepsy drug that calms brain activity

New Alzheimer trial to use epilepsy drug that calms brain activity

by Scott Dance, The Baltimore SunWhat could be one of the first treatments to delay or prevent Alzheimer's disease received a big boost from the National Institute on Aging, which is putting up $7

New Alzheimer trial to use epilepsy drug that calms brain activity

by Scott Dance, The Baltimore SunWhat could be one of the first treatments to delay or prevent Alzheimer's disease received a big boost from the National Institute on Aging, which is putting up $7
Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A
Development of plaques in Alzheimer's disease resolved

Development of plaques in Alzheimer's disease resolved

by Ruhr-Universitaet-BochumDominik Röhr researches proteins that are altered in Alzheimer’s disease. Credit: Michael SchwettmannA team of researchers from Ruhr-Universität Bochum (RUB) and Vrije

Development of plaques in Alzheimer's disease resolved

by Ruhr-Universitaet-BochumDominik Röhr researches proteins that are altered in Alzheimer’s disease. Credit: Michael SchwettmannA team of researchers from Ruhr-Universität Bochum (RUB) and Vrije